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My interest in inherited eye disease was initiated at the genetic outreach 
clinics conducted by the University of Cape Town (UCT) Department 
of Human Genetics at schools for visually and hearing-impaired 
children in the Western Cape. As a clinical registrar from 1992 to 
1998, I accom panied Prof. Peter Beighton on numerous clinics, where 
I developed a fascination for understanding the genetic mechanisms 
underlying the sensory deficits affecting many of the children and their 
families. This led to a research initiative into the molecular genetics of 
profound childhood deafness in South Africa, which became the topic 
of my PhD thesis. Prof. Beighton is an inspirational teacher and one of 
the first clinical genetics lectures he gave to medical students at UCT 
began with a whirlwind tour of genetic conditions around the world. 
One of the conditions he described was the X-linked eye condition 
Bornholm eye disease; and another, a severe autosomal form of colour 
blindness affecting the Indonesian islanders of Pingelap, whose disorder, 
achromatopsia, was caused by an early settler who carried a rare 
recessive founder mutation. So it was, with a sense of déjà vu, that over 
20 years later at the University College of London (UCL) Institute of 
Ophthalmology, UK, I started a research project to evaluate the role of 
the cone opsins in a panel of British male patients at Moorfields Eye 
Hospital, London, with a variety of retinal eye conditions ranging from 
Bornholm eye disease to X-linked incomplete achromatopsia (blue cone 
monochromacy) and X-linked cone dystrophy. I present a synopsis 
of X-linked cone opsin disorders and review recent work on their 
phenotypes and genotypes. It gives me great pleasure as a former PhD 
student of Prof. Beighton’s to write this article in his honour. 
Background
Mutations in the human long wavelength- and middle wavelength-
sensitive cone opsin genes cause several X-linked cone vision defects 
including red-green colour blindness (MIM 303800, MIM 303900), 
X-linked cone dysfunction (MIM 300843), blue cone monochromacy 
(BCM; MIM 303700) and X-linked cone dystrophy (COD5; MIM 
303700).[1-5] These allelic X-linked cone opsin disorders display wide 
inter- and intrafamilial variability. However, in the majority the 
visual defect is non-progressive. A few, conversely, show signs of 
deterioration with increasing visual impairment, macular atrophy, 
retinal pigmentation and electroretinographic (ERG) dysfunction 
of S cones and rods.[4-9] In these it appears that the presence of 
dysfunctional opsin results in degeneration of the photoreceptor. 
Recent studies have shown that cone opsin disorders, with specific 
visual and retinal phenotypes, are caused by several different genetic 
mechanisms.[10-12] As a result, genotype-phenotype correlations are 
beginning to emerge that influence predictions of the course and 
severity of disease.
X-linked cone photoreceptor disorders
The photoreceptor layer of the retina is composed of a mosaic of 
L (red), M (green) and S (blue) cones, interspersed by rods. Cones 
are most abundant in the central retina and are responsible for 
colour vision, daylight vision and high visual acuity, while rods 
are responsible for peripheral and low-light vision. Normal human 
trichromatic colour vision requires three functioning classes of 
cone, each characterised by a constituent photopigment with a 
specific range of light sensitivity. Photopigments are comprised of 
an opsin protein linked to a light-sensitive chromophore and the 
spectral sensitivity of the pigment is determined by the amino acid 
sequence of the opsin.[1] Stimulation of the photopigment generates 
an electrical signal that is processed with signals from all three 
cone types before the combination is interpreted as trichromatic 
colour perception in humans. Loss of one cone type results in the 
dichromatic colour vision disorders protanopia (loss of functional L 
cones) and deuteranopia (loss of functional M cones). 
Both the L and M cone opsin genes (OPN1LW and OPN1MW) 
are located in a head-to-tail arrangement on chromosome Xq28, and 
loss of both L and M cone types causes X-linked BCM, alternatively 
known as incomplete achromatopsia.[1,4] Affected individuals have 
severe loss of colour vision and visual acuity from birth, frequently 
with photophobia and nystagmus. In young subjects, BCM can 
appear similar to X-linked cone dystrophy (XLCD), an allelic 
disorder that shares many clinical features with BCM, but which has 
a later onset of symptoms and a progressive course.
Bornholm eye disease (BED; MIM 300843) is an X-linked cone 
dysfunction disorder characterised by myopia, astigmatism, impaired 
visual acuity, optic nerve hypoplasia, abnormal retinal pigmentation 
and reduced cone ERG responses.[13] Originally described in a large 
kindred from the island of Bornholm in Denmark with deuteranopia, 
and later in several families with protanopia, this type of cone 
dysfunction is associated with loss of function mutations in the cone 
opsin array.[2,3,14]
XLCD is a heterogeneous condition characterised by loss of 
colour vision, impaired visual acuity, macular atrophy and ERG 
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evidence of severe disturbance of L and/or M 
cone function, often with additional S cone 
and occasional rod involvement. XLCD is 
most often associated with mutations of the 
retinitis pigmentosa GTPase regulator gene 
(RPGR) on chromosome Xp11.4. However, 
several large XLCD kindreds were found to 
be negative for mutations in RPGR. Linkage 
analysis and subsequent candidate gene 
screening in one of these families revealed 
a novel missense mutation in a highly 
conserved residue (c.529T>C; p.Trp 177Arg) 
in exon 3 of both L and M opsin genes. 
Interestingly, the variant was found within 
a region of identical sequence in the two 
genes, indicating that it had been transferred 
from the M gene to the L gene by means of 
a partial gene conversion, a process whereby 
sequence is transferred from one gene to 
another without any change occurring in the 
donor sequence.[5] 
Molecular genetics of the 
cone opsin gene array
OPN1LW and OPN1MW are duplicated genes 
that arose from a single opsin primate ancestor. 
The genes retain 98% sequence similarity and 
their close proximity and nose-to-tail genetic 
arrangement results in frequent meiotic mis-
pairing and non-homologous recombination, 
and less commonly, in gene conversion events. 
This genetic predisposition to structural 
rearrangement has led to the introduction 
and maintenance of a great variety of color 
vision phenotypes, both normal and deficient, 
in modern-day humans. 
The L and M opsin genes in the ancestral 
opsin array lie adjacent to one another 
with a single L gene lying upstream of one 
or more M genes (Fig. 1). The number 
of genes in the arrays of modern humans 
varies considerably, however, only the first 
two genes are expressed in the retina. A 
mature photoreceptor expresses only one 
opsin, and the gene that is selectively 
expressed determines the L or M destiny of 
the photoreceptor. The selection process is 
driven by an upstream regulatory sequence 
or locus control region (LCR) that interacts 
with specific promoters of the first or second 
gene in the array.[1]
The L and M opsin genes have six exons. 
Exons 1 and 6 are identical between L and M 
genes with all sequence variation occurring 
in exons 2 - 5. In exon 5, there are seven 
amino acids that vary and these help to 
define the opsin, because two residues (at 
positions p.277 and p.285) are responsible 
for most of the spectral difference between 
L and M pigments. In exons 2, 3 and 4 there 
are eleven sites at which the amino acids can 
vary as a result of recombination between 
the ancestral L and M genes. Four of these 
are dimorphisms (at positions p.116, p.180, 
p.230 and p.233) that affect the absorption 
spectra of the opsin, while the remainder are 
individually believed to be functionally and 
visually neutral.
Genetic mechanisms of 
X-linked opsin disorders
Stable red-green colour vision deficiency 
with normal visual acuity is common, 
affecting ~8% of males.[15] Often this occurs 
as a consequence of a complete or partial 
deletion of either the L or M gene, leaving 
only a single functional gene to be expressed 
in all cones that, in a normal individual, 
would have been destined to be L or M; 
hence the difficulty in differentiating colour 
in the red/green spectrum. In phenotypes 
where a colour vision disorder is associated 
with loss of visual acuity, a number of 
causative mutations have been identified 
and classified according to their mechanism 
of action.
The first mechanism, a common cause of 
BCM, involves large-scale deletions of the 
LCR, which result in a complete absence of 
expression of both L and M cone opsin.[4]
A second mechanism involves inactivation of 
one or more genes in the array by a missense 
mutation causing an amino acid change, 
or a partial deletion. Opsins with missense 
mutations are expressed, but some, including 
the common pathogenic variant c.607T>C 
p.Cys203Arg, are mis-folded and become 
mis-localised within the cell, resulting in 
an inability to bind the chromophore. The 
p.Cys203Arg mutation disrupts a critical 
di-sulphide bond that causes the protein 
to mis-fold, forming a non-functional 
opsin.[16] Similarly, the missense mutation 
p.Trp177Arg that causes XLCD, also mis-
folds and is retained in the endoplasmic 
reticulum.[5] Toxic aggregation of the mis-
folded mutant protein may be the cause of 
photoreceptor cell death and a degenerative 
phenotype.
Other mutant cone opsins could also have 
the potential to mis-fold. In a molecular 
study of BCM, a family was reported in 
which the affected males had a single hybrid 
gene with a deletion of exon 2. The deletion 
was not predicted to cause a frame shift 
in the protein and it would therefore be 
unlikely to undergo nonsense mediated 
decay (NMD). Instead, misfolding and toxic 
aggregation of the mutant protein could 
explain the progressive phenotype in this 
family.[9]
A third mechanism that has recently been 
recognised as a significant cause of X-linked 
opsin disorders involves the unexpected 
deleterious effects of specific combinations 
in exon 3 of normal polymorphisms that 
arose by genetic recombination between 
the L and M opsin genes. One such 
combination of polymorphisms was first 
noted by Nathans as the only change in a 
family with BCM, but it was not initially 
thought to be significant.[4] This family 
had a set, or haplotype, of common DNA 
variations (Table 1) in exon 3 that would 
normally translate to a series of amino acids 
p.[153Leu; 171Ile; 174Ala; 178Val; 180Ala]. 
This haplotype is commonly referred to as 
LIAVA, a term comprising the first letters 
of each variant amino acid in the series. 
This same haplotype was subsequently 
associated with XLCD and BCM in several 
studies.[17-19] A second rare haplotype of 
nucleotide variants (Table 1) translating to 
p.[153Leu; 171Val; 174Ala; 178Val; 180Ala] 
or LVAVA, has also been associated with XL 
cone dysfunction,[20]  BCM and with cone 
dystrophy.[10,12,14] However, we now know 
that it is not the amino acid changes that 
are causing disease but the combinations 
of nucleotides. The single nucleotide 
variants comprising the LIAVA and LVAVA 
haplotypes are common (MAF >0.05 among 
OPN1LW OPN1MW
chrXq28
n
Fig. 1. Schematic of the wild type L (OPN1LW) and M (OPN1MW) opsin gene array on chromo-
some Xq28. The L and M genes are arranged in tandem with the L gene in a 5’ position to one or 
more (n=1 - 6) M genes. The genes have 6 exons (boxes). Interaction of the LCR (black circle) with the 
promoter (oval) determines gene expression.
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individuals with colour normal vision) and are therefore not thought 
to be individually deleterious. However, in combination, they are 
associated with a loss of opsin function. The mechanism of disease 
caused by these rare haplotypes was unknown until recently, when 
it was discovered that the nucleotide combination resulting in an 
LIAVA haplotype interferes with normal recognition by the splicing 
mechanism in opsin pre-mRNA of exon 3. This causes it to be 
skipped in the resulting transcript.[21] The pathogenicity of exon 3 
haplotypes was further established in a detailed study of BCM and 
XLCD phenotypes and genotypes in a British cohort of patients.[12] In 
this study, 41% of the affected males were found to have an unusual 
exon 3 haplotype, indicating that as a group, these haplotypes are a 
relatively common cause of opsin disorders and more frequent than 
either missense mutations or LCR deletions. LIAVA and LVAVA 
haplotypes were both found in the cohort in addition to a novel 
haplotype, MIAVA. These rare combinations of exon 3 nucleotides 
(Table 1), associated with disease, are collectively referred to as 
interchange (IC) haplotypes. In a functional investigation of the three 
IC haplotypes using a splicing assay, all three combinations of 
nucleotide polymorphisms were shown to interfere with normal pre-
mRNA splicing. There were differences in exon skipping between the 
three haplotypes, and in the relative amount of transcript produced, 
suggesting different haplotypes cause different splicing patterns. The 
aberrant transcripts are predicted to result in a codon frame-shift and 
generation of a premature stop codon in exon 4 that would result in a 
truncated polypeptide, if expressed.However, the aberrant transcripts 
are likely to be removed by NMD.
Genotype-phenotype correlations
Although there is considerable phenotypic variation among subjects, 
observations from several studies indicate that subjects with LCR 
deletions are more likely to have congenital or very early onset of poor 
vision, nystagmus and myopia, with normal fundi and little evidence 
of progression.[10,12] Subjects with p.Cys203Arg also display congenital 
loss of colour vision and most are stable, but some older individuals 
show evidence of macular changes. Subjects with p.Trp177Arg had 
a more gradual onset of visual disturbance but developed extensive 
macular dystrophy and cone photoreceptor loss. Individuals with 
IC haplotypes also had a later onset of visual disturbance but were 
generally more progressive, showing macular changes after 40 years 
of age and dysfunction of both cone and rod systems on ERG. 
Retinal imaging using high-definition optical coherence 
tomography and adaptive optics scanning light ophthalmoscopy 
shows distinct differences in the effects of LCR, missense and IC 
haplotype mutations on the integrity of the retinal layers and the 
structure of the cone mosaic.[10,11] While all mutations resulted 
in reduced retinal thickness and disruption of the photoreceptor 
mosaic, there were distinct patterns in the distribution and extent of 
the disruption between genotypes. Those with predominantly stable 
phenotypes (LCR deletions and p.Cys203Arg) had largely preserved 
lamination of the retina with disruption confined to a focal section 
only of the inner segment (Ise) layer, which corresponded to the S 
cone free zone of the fovea. Structural changes were specific to the L 
and M cones only. In contrast, subjects with progressive phenotypes 
(including exon 2 deletion and IC haplotypes) had widespread 
retinal thinning and disruption of cone structure, particularly in 
the fovea, with loss of L, M and S cones. Interestingly, despite severe 
foveal disruption, the IC haplotypes had better cone structure in the 
parafovea than the missense mutants, indicating that at least some L 
and M cones remain viable in these conditions. Of the IC haplotypes, 
LIAVA appears to be the least disruptive, showing normal inner 
retinal thickness and no change in cone structure in one subject over 
a period of 8 years.
Discussion
Variation in the clinical manifestation of the cone opsin disorders 
is well recognised but only recently have advances in genetics and 
imaging started to reveal underlying mechanisms of disease and 
to enable genomic subclassification of X-linked opsin disorders. 
The IC haplotypes illustrate an unexpected genetic mechanism 
that appears to be a frequent cause of severe cone dysfunction in 
both monochromatic (BCM) and dichromatic (BED) colour vision 
disorders.[12,14] The effects of these haplotypes on splicing depends 
on the combination of variants, so some may be degenerative while 
others are not. LVAVA has a progressive visual phenotype that is 
reflected in additional damage to the S cones and rods neighbouring 
mutant L/M cones. In contrast, retinal imaging of LIAVA suggests 
it may not result in the progressive loss of L/M cones (or it occurs 
much more slowly). [10] The difference may be related to the variable 
splicing effects of the haplotypes; LIAVA produces only a single 
aberrant transcript that is likely to undergo NMD, causing a 
congenital loss of cone function. LVAVA and MIAVA result in the 
production of several transcripts, one of which is normal opsin. [12] 
This could explain the later onset of visual impairment in some 
haplotypes and also the presence of a small remaining population 
of parafoveal L and M cones on retinal imaging. Although the 
Table 1. Exon 3 reference and IC haplotypes
Opsin/
Exon 3 haplotype Opsin function
Exon 3 DNA haplotypes, coding nucleotide variant and corresponding amino acid positions
c.453
p.151
c.457
p.153
c.465
p.155
c.511
p.171
c.513
p.171
c.521
p.174
c.532
p.178
c.538
p.180
L opsin 
LVAIS
Normal g c
L
g g
V
g c
A
a
I
t
S
M opsin
MVAIA
Normal a a
M
c g
V
g c
A
a
I
g
A
IC opsin
LIAVA
Affected g c
L
g a
I
t c
A
g
V
g
A
IC opsin
LVAVA
Affected g c
L
g g
V
g c
A
g
V
g
A
IC opsin
MIAVA
Affected a a
M
c/g a
I
t c
A
g
V
g
A
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precise cause of photoreceptor degeneration is not understood, the 
retinoid byproducts of the visual cycle are cytotoxic. It is possible 
that the cones expressing the IC mutants remain viable through 
young adulthood but cannot operate normally in the visual cycle. 
This could lead to accumulation of toxic retinoids, affecting not 
only the cones expressing the mutant opsin, but also parafoveal S 
cones and rods. 
Description of mutation-specific retinal phenotypes is 
particularly pertinent now that advances in gene replacement 
therapy are beginning to make prospects of restoration of cone 
function a reality. The genotypes with the greatest degree of 
cone preservation are the best candidates for intervention. In IC 
haplotypes, macular degeneration would limit the therapeutic 
time frame at later stages of the disease. However, strategies may 
be developed to slow the degenerative effects of these mutations. It 
will be important to assess the progressive nature of the various IC 
mutations and others to better determine the therapeutic potential 
in these individuals.
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